Drug-maker Wockhardt Ltd and its subsidiary have agreed to divest their nutritional business to French company Danone, one of the fastest growing food-companies in the world.
Under the agreement, Danone will acquire Wockhardt's nutrition business and brands as well as its related industrial operations from Carol Info Service (located in Punjab) for approximately €250 million (about Rs 1,600 crore), Danone said. The acquisition will provide Danone access to a distribution network with nationwide reach. Wockhardt's nutritional business comprises Farex, Dexolac, Nusobee and Protinex. These transactions are subject to customary closing conditions and various approvals.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.